AAPL337.02-2.73 (-0.80%) ▼|ABBV265.08-0.13 (-0.05%) ▼|ABT103.49-0.20 (-0.19%) ▼|ACN183.52-0.20 (-0.11%) ▼|ADBE240.69+2.44 (+1.02%) ▲|AMAT474.38+1.92 (+0.41%) ▲|AMD614.61-9.16 (-1.47%) ▼|AMGN406.09-4.15 (-1.01%) ▼|AMT170.78-4.47 (-2.55%) ▼|AMZN249.27-5.71 (-2.24%) ▼|AVGO354.99-9.55 (-2.62%) ▼|AXP301.96-3.11 (-1.02%) ▼|BA199.93+2.21 (+1.12%) ▲|BAC56.00-0.20 (-0.36%) ▼|BKNG155.90-8.32 (-5.07%) ▼|BLK1,060.89-5.77 (-0.54%) ▼|BMY61.15-1.10 (-1.77%) ▼|BNY149.51-0.66 (-0.44%) ▼|BRK-B507.17+3.68 (+0.73%) ▲|C131.93-0.54 (-0.41%) ▼|CAT812.02+4.01 (+0.50%) ▲|CL85.93-1.12 (-1.29%) ▼|CMCSA22.55+0.13 (+0.58%) ▲|COF196.10-4.45 (-2.22%) ▼|COP128.09+2.82 (+2.25%) ▲|COST904.70+5.29 (+0.59%) ▲|CRM237.58+4.30 (+1.84%) ▲|CSCO106.43-0.01 (-0.01%) ▼|CVS85.86-1.24 (-1.42%) ▼|CVX205.51+3.10 (+1.53%) ▲|DE709.48+6.36 (+0.90%) ▲|DHR221.56+0.47 (+0.21%) ▲|DIS103.46-0.36 (-0.35%) ▼|DUK114.17-2.14 (-1.84%) ▼|EMR154.59+0.40 (+0.26%) ▲|FDX291.50-4.44 (-1.50%) ▼|GD343.33-0.06 (-0.02%) ▼|GE319.80+0.58 (+0.18%) ▲|GEV951.82+1.54 (+0.16%) ▲|GILD151.37-1.30 (-0.85%) ▼|GM83.77+0.32 (+0.38%) ▲|GOOG334.98-12.43 (-3.58%) ▼|GOOGL337.83-13.33 (-3.80%) ▼|GS936.36-13.13 (-1.38%) ▼|HD296.72-8.63 (-2.83%) ▼|HON212.57+0.72 (+0.34%) ▲|IBM232.76+1.38 (+0.60%) ▲|INTC122.60-1.26 (-1.02%) ▼|INTU286.80-5.55 (-1.90%) ▼|ISRG398.30-3.79 (-0.94%) ▼|JNJ269.17-0.02 (-0.01%) ▼|JPM337.53-2.47 (-0.73%) ▼|KO88.09-0.52 (-0.59%) ▼|LIN469.72+4.81 (+1.03%) ▲|LLY1,150.99-19.15 (-1.64%) ▼|LMT524.68+2.34 (+0.45%) ▲|LOW191.36-4.72 (-2.41%) ▼|LRCX307.28-3.35 (-1.08%) ▼|MA559.92+4.03 (+0.73%) ▲|MCD238.32-12.03 (-4.81%) ▼|MDLZ61.44+0.36 (+0.59%) ▲|MDT89.30-1.47 (-1.62%) ▼|META744.10+7.51 (+1.02%) ▲|MMM170.30+1.00 (+0.59%) ▲|MO68.95+0.31 (+0.45%) ▲|MRK148.08-2.83 (-1.88%) ▼|MS198.39-1.79 (-0.89%) ▼|MSFT500.59+2.59 (+0.52%) ▲|MU1,071.88-24.28 (-2.22%) ▼|NEE77.02-2.24 (-2.83%) ▼|NFLX71.36-0.80 (-1.11%) ▼|NKE36.05-0.05 (-0.14%) ▼|NOW140.78+3.78 (+2.76%) ▲|NVDA225.51-3.36 (-1.47%) ▼|ORCL144.56-4.64 (-3.11%) ▼|PEP130.18-1.01 (-0.77%) ▼|PFE28.18+0.25 (+0.90%) ▲|PG147.39-0.83 (-0.56%) ▼|PLTR191.79+6.80 (+3.68%) ▲|PM190.84+0.61 (+0.32%) ▲|QCOM197.24-1.03 (-0.52%) ▼|RTX192.19+1.20 (+0.63%) ▲|SBUX94.14-0.97 (-1.02%) ▼|SCHW99.50-0.85 (-0.85%) ▼|SO83.47-1.68 (-1.97%) ▼|SPG204.16-1.79 (-0.87%) ▼|T25.30+0.20 (+0.80%) ▲|TMO665.30+6.78 (+1.03%) ▲|TMUS165.66+3.25 (+2.00%) ▲|TSLA380.12+1.22 (+0.32%) ▲|TXN272.62+1.21 (+0.45%) ▲|UBER69.42-0.47 (-0.67%) ▼|UNH371.29-1.66 (-0.45%) ▼|UNP275.53+1.12 (+0.41%) ▲|UPS95.82-0.05 (-0.05%) ▼|USB58.48-0.96 (-1.62%) ▼|V361.52-0.52 (-0.14%) ▼|VZ46.52+0.07 (+0.15%) ▲|WFC81.90-1.25 (-1.50%) ▼|WMT110.53+0.41 (+0.37%) ▲|XOM161.23+2.52 (+1.59%) ▲|AAPL337.02-2.73 (-0.80%) ▼|ABBV265.08-0.13 (-0.05%) ▼|ABT103.49-0.20 (-0.19%) ▼|ACN183.52-0.20 (-0.11%) ▼|ADBE240.69+2.44 (+1.02%) ▲|AMAT474.38+1.92 (+0.41%) ▲|AMD614.61-9.16 (-1.47%) ▼|AMGN406.09-4.15 (-1.01%) ▼|AMT170.78-4.47 (-2.55%) ▼|AMZN249.27-5.71 (-2.24%) ▼|AVGO354.99-9.55 (-2.62%) ▼|AXP301.96-3.11 (-1.02%) ▼|BA199.93+2.21 (+1.12%) ▲|BAC56.00-0.20 (-0.36%) ▼|BKNG155.90-8.32 (-5.07%) ▼|BLK1,060.89-5.77 (-0.54%) ▼|BMY61.15-1.10 (-1.77%) ▼|BNY149.51-0.66 (-0.44%) ▼|BRK-B507.17+3.68 (+0.73%) ▲|C131.93-0.54 (-0.41%) ▼|CAT812.02+4.01 (+0.50%) ▲|CL85.93-1.12 (-1.29%) ▼|CMCSA22.55+0.13 (+0.58%) ▲|COF196.10-4.45 (-2.22%) ▼|COP128.09+2.82 (+2.25%) ▲|COST904.70+5.29 (+0.59%) ▲|CRM237.58+4.30 (+1.84%) ▲|CSCO106.43-0.01 (-0.01%) ▼|CVS85.86-1.24 (-1.42%) ▼|CVX205.51+3.10 (+1.53%) ▲|DE709.48+6.36 (+0.90%) ▲|DHR221.56+0.47 (+0.21%) ▲|DIS103.46-0.36 (-0.35%) ▼|DUK114.17-2.14 (-1.84%) ▼|EMR154.59+0.40 (+0.26%) ▲|FDX291.50-4.44 (-1.50%) ▼|GD343.33-0.06 (-0.02%) ▼|GE319.80+0.58 (+0.18%) ▲|GEV951.82+1.54 (+0.16%) ▲|GILD151.37-1.30 (-0.85%) ▼|GM83.77+0.32 (+0.38%) ▲|GOOG334.98-12.43 (-3.58%) ▼|GOOGL337.83-13.33 (-3.80%) ▼|GS936.36-13.13 (-1.38%) ▼|HD296.72-8.63 (-2.83%) ▼|HON212.57+0.72 (+0.34%) ▲|IBM232.76+1.38 (+0.60%) ▲|INTC122.60-1.26 (-1.02%) ▼|INTU286.80-5.55 (-1.90%) ▼|ISRG398.30-3.79 (-0.94%) ▼|JNJ269.17-0.02 (-0.01%) ▼|JPM337.53-2.47 (-0.73%) ▼|KO88.09-0.52 (-0.59%) ▼|LIN469.72+4.81 (+1.03%) ▲|LLY1,150.99-19.15 (-1.64%) ▼|LMT524.68+2.34 (+0.45%) ▲|LOW191.36-4.72 (-2.41%) ▼|LRCX307.28-3.35 (-1.08%) ▼|MA559.92+4.03 (+0.73%) ▲|MCD238.32-12.03 (-4.81%) ▼|MDLZ61.44+0.36 (+0.59%) ▲|MDT89.30-1.47 (-1.62%) ▼|META744.10+7.51 (+1.02%) ▲|MMM170.30+1.00 (+0.59%) ▲|MO68.95+0.31 (+0.45%) ▲|MRK148.08-2.83 (-1.88%) ▼|MS198.39-1.79 (-0.89%) ▼|MSFT500.59+2.59 (+0.52%) ▲|MU1,071.88-24.28 (-2.22%) ▼|NEE77.02-2.24 (-2.83%) ▼|NFLX71.36-0.80 (-1.11%) ▼|NKE36.05-0.05 (-0.14%) ▼|NOW140.78+3.78 (+2.76%) ▲|NVDA225.51-3.36 (-1.47%) ▼|ORCL144.56-4.64 (-3.11%) ▼|PEP130.18-1.01 (-0.77%) ▼|PFE28.18+0.25 (+0.90%) ▲|PG147.39-0.83 (-0.56%) ▼|PLTR191.79+6.80 (+3.68%) ▲|PM190.84+0.61 (+0.32%) ▲|QCOM197.24-1.03 (-0.52%) ▼|RTX192.19+1.20 (+0.63%) ▲|SBUX94.14-0.97 (-1.02%) ▼|SCHW99.50-0.85 (-0.85%) ▼|SO83.47-1.68 (-1.97%) ▼|SPG204.16-1.79 (-0.87%) ▼|T25.30+0.20 (+0.80%) ▲|TMO665.30+6.78 (+1.03%) ▲|TMUS165.66+3.25 (+2.00%) ▲|TSLA380.12+1.22 (+0.32%) ▲|TXN272.62+1.21 (+0.45%) ▲|UBER69.42-0.47 (-0.67%) ▼|UNH371.29-1.66 (-0.45%) ▼|UNP275.53+1.12 (+0.41%) ▲|UPS95.82-0.05 (-0.05%) ▼|USB58.48-0.96 (-1.62%) ▼|V361.52-0.52 (-0.14%) ▼|VZ46.52+0.07 (+0.15%) ▲|WFC81.90-1.25 (-1.50%) ▼|WMT110.53+0.41 (+0.37%) ▲|XOM161.23+2.52 (+1.59%) ▲|

17.2 C

New York

Thursday, September 24, 2026

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages America’s Car-Mart, Inc. Investors to Inquire About Securities Class Action Investigation – CRMT

NWPX Infrastructure Names John Schillie Vice President and General Manager of NWPX Park

Ultimate Longevity Center Launches in Australia, Pushing Global Footprint Past 300 Territories

Tag: years

Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with hemophilia A in new phase 3 data presented at the...

New FRONTIER5 results show a direct switch to investigational Mim8 (denecimig) prophylaxis treatment from emicizumab, without the need for a washout period, was well-tolerated...

Big Tech Execs Play Soldier—What a Joke

You can't make this stuff up: Silicon Valley execs are now donning Army fatigues. Meta's CTO Andrew "Boz" Bosworth, and a few other tech...

Revolutionary Research by Dr. Takuma Hayashi Uncovers Molecular Origins of Deadly Uterine Cancer and Charts New Path for Treatment

In a landmark advancement for women's cancer research, Dr. Takuma Hayashi and his team have made groundbreaking discoveries that could transform our understanding and...

Lilly’s once-weekly insulin efsitora alfa demonstrated A1C reduction and a safety profile consistent with daily insulin in multiple Phase 3 trials

Results from the fixed-dose QWINT-1 study, along with the QWINT-3 and QWINT-4 studies, reinforce efsitora's potential to simplify insulin management with weekly dosing Lilly plans...

Inhaled Insulin Shown as a Safe and Effective Replacement for Standard-of-Care in Children with Type 1 Diabetes

Findings Highlight Potential for Novel Approach to Insulin Delivery in Pediatric Population CHICAGO, June 22, 2025 /PRNewswire/ -- Today, a new study demonstrates inhaled insulin...

Once-Weekly Insulin Efsitora Achieves Comparable A1C Reduction to Daily Insulin Therapy

Once-weekly insulin helped patients achieve an average A1C of 6.92% in QWINT-1 trial Results support once-weekly insulin as effective alternative to daily treatment CHICAGO, June 22,...

INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Red Cat Holdings, Inc. (RCAT) Investors with Substantial Losses Have Opportunity to Lead Investor...

SAN DIEGO, June 22, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Red Cat Holdings, Inc. (NASDAQ: RCAT) securities between March 18, 2022 and January 15, 2025, inclusive (the “Class Period”), have until Tuesday, July 22, 2025 to seek appointment as lead plaintiff of the Red Cat class action lawsuit. Captioned Olsen v. Red Cat Holdings, Inc., No. 25-cv-05427 (D.N.J.), the Red Cat class action lawsuit charges Red Cat as well as certain of Red Cat’s top current and former executives with violations of the Securities Exchange Act of 1934.

From Cult Thriller to Real-Life Dares: The Producers of Would You Rather Launch CAJOLE — A Platform Asking How Far You’d Go for the...

LOS ANGELES, June 22, 2025 /PRNewswire/ -- What would it take for you to be buried alive? Pour a bucket of nacho cheese over...

Pizza 73 Celebrates the Heart of Oil Country with Free Heart Pizzas for Fans

EDMONTON, AB, June 22, 2025 /CNW/ - Pizza 73, the beloved Alberta-born pizza chain and official pizza partner of the Edmonton Oilers, is celebrating Oilers...

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages DoubleVerify Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DV

NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of DoubleVerify Holdings, Inc. (NYSE: DV) between November 10, 2023 and February 27, 2025, both dates inclusive (the “Class Period”), of the important July 21, 2025 lead plaintiff deadline.

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsYears

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages America’s Car-Mart, Inc. Investors to Inquire About Securities Class Action Investigation – CRMT

NWPX Infrastructure Names John Schillie Vice President and General Manager of NWPX Park

Ultimate Longevity Center Launches in Australia, Pushing Global Footprint Past 300 Territories

Tag: years

Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with hemophilia A in new phase 3 data presented at the...

Big Tech Execs Play Soldier—What a Joke

Revolutionary Research by Dr. Takuma Hayashi Uncovers Molecular Origins of Deadly Uterine Cancer and Charts New Path for Treatment

Lilly’s once-weekly insulin efsitora alfa demonstrated A1C reduction and a safety profile consistent with daily insulin in multiple Phase 3 trials

Inhaled Insulin Shown as a Safe and Effective Replacement for Standard-of-Care in Children with Type 1 Diabetes

Once-Weekly Insulin Efsitora Achieves Comparable A1C Reduction to Daily Insulin Therapy

INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Red Cat Holdings, Inc. (RCAT) Investors with Substantial Losses Have Opportunity to Lead Investor...

From Cult Thriller to Real-Life Dares: The Producers of Would You Rather Launch CAJOLE — A Platform Asking How Far You’d Go for the...

Pizza 73 Celebrates the Heart of Oil Country with Free Heart Pizzas for Fans

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages DoubleVerify Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DV

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. – PTCT

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 3D Systems Corporation – DDD

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sable Offshore Corp. – SOC

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. – NPCE

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us